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UMR 5248, Universite´ Bordeaux 1, Pessac, FranceABSTRACT Amyloids are thought to be involved in various types of neurodegenerative disorders. Several kinds of interme-
diates, differing in morphology, size, and toxicity, have been identified in the multistep amyloidogenesis process. However,
the mechanisms explaining amyloid toxicity remain unclear. We previously generated a toxic mutant of the nontoxic HET-
s(218-289) amyloid in yeast. Here we report that toxic and nontoxic amyloids differ not only in their structures but also in their
assembling process. We used multiple and complementary methods to investigate the intermediates formed by these two
amyloids. With the methods used, no intermediates were observed for the nontoxic amyloid; however, under the same exper-
imental conditions, the toxic mutant displayed visible oligomeric and fibrillar intermediates.INTRODUCTIONAmyloid deposits are associated with >40 human patholo-
gies, including type II diabetes, Alzheimer’s disease and
prion disease (for review see (1,2)). Despite extensive
research into amyloid toxicity, the mechanisms that cause
this cytotoxicity are far from clear. Several studies have
suggested the involvement of intermediate species such as
oligomers (3–5), annular or short/quiescent fibrils (6–8),
and membrane pores/channels (9,10); others have shown
toxicity to be associated with mature fibrils (11,12).
Amyloid toxicity may be independent of the polypeptide
length, primary sequence, or chirality (13). It has also
been suggested that the toxic species could interact inappro-
priately with a wide range of cellular components, particu-
larly biological membranes (14–16).
Amyloids may be very diverse in their primary sequences.
However, they all share typical self-assembly into fibrils,
fibers, or aggregates with a cross-b architecture (4.7 A˚ x-ray
diffraction pattern), which is characteristically proteinase-
resistant. When stained by Congo Red, amyloid fibers also
exhibit birefringence by observation under cross-polarized
light microscopy (17).
HET-s is a 289-amino-acid protein of the filamentous
fungus Podospora anserina. It has the characteristic features
of prion proteins: infectivity and amyloid folding. The
prion-forming domain extending from amino acid 218 to
289 (HET-s(218–289)) has been well characterized as amyloid
fibers by solid-state NMR (18), and is not toxic when ex-
pressed in yeast Saccharomyces cerevisiae (1). In previous
studies, we used error-prone polymerase chain reaction
mutagenesis to generate several mutants that were toxic to
the yeast (1) and characterized a new toxic mutant called
M8, an amyloid protein showing different types of struc-Submitted April 20, 2010, and accepted for publication June 9, 2010.
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b-sheets in an antiparallel orientation. In this study, we
investigated the features that may explain the toxicity of
this M8 mutant. We thus used various approaches to inves-
tigate and compare the dynamics of the polymerization of
this mutant and of the wild-type (WT) protein. We neatly
showed that, indeed, the M8 toxic mutant assembly occurs
through a totally different amyloidogenic pathway,
involving structured on-pathway intermediates that are not
observed during the nontoxic amyloid fibrilization.
MATERIALS AND METHODS
Prion-forming domain expression and
purification
The C-terminal histidine-tagged HET-s(218–289) constructs (WT and M8 ;
Fig. 1 A) were introduced in Escherichia coli BL21(DE3) pLysS Gold cells.
Bacteriaweregrown to 1OD in2xYTmedium(16g /LTryptone, 10 g/LYeast
Extract, and 5.0 g/LNaCl), and expression was induced by addition of 1mM
isopropyl-D-thiogalactoside (Euromedex, Souffelweyersheim, France).
After 4 h induction, cells were harvested by centrifugation and frozen at
20C. Cells were sonicated 4  1 min in buffer A (150 mM NaCl and
100 mM Tris-HCl, pH 8.0). The lysate was centrifuged for 30 min at
20,000 g. The pellet was washed in the buffer A and resuspended in dena-
turing buffer (6 M guanidinium/HCl in buffer A). The lysate was incubated
with 2 mLTALON resin (Takara Bio Europe/Clontech, Saint-Germain-en-
Laye, France) for 3 h at room temperature. The resin was then washed twice
with 35 mL of 8 M urea/buffer A, by centrifuging 10 min at 900 g. The
peptides were eluted from the resin in the same buffer containing 250 mM
imidazole (Sigma-Aldrich, Saint Louis, MO) and kept aliquoted at 80C.
This yields ~2–4 mg of peptide per liter of culture. The peptide was pure
as judged by analysis on 15% sodium dodecyl sulfate polyacrylamide gel
electrophoresis followed by Coomassie Blue staining. Protein concentra-
tions were determined by quantitative amino-acid analysis.
Fiber polymerization
For renaturation, proteins were subjected to gel filtration on a Hi-Trap
Sephadex G-25 column (GE Healthcare Europe, Orsay, France) at 4C,
using 10 mM HCl pH 2.0 as the eluent. pH was then increased to 7.4 bydoi: 10.1016/j.bpj.2010.06.015
FIGURE 1 Soluble and aggregated forms of the
two proteins display different antibody-binding
characteristics during amyloidogenesis. (A) Se-
quence of HET-s(218-289) (WT) and M8 toxic
mutant. (B) Detection of soluble proteins (pH 2.0
just after desalting) and amyloid fibers formed after
several days at pH 7.4 with Ponceau Red and anti-
histidine antibody (a-His Ab). (C) Kinetics of
polymerization followed with anti-His-tag anti-
body demonstrate that this antibody shows almost
no binding affinity for soluble WT (T0 at pH 7.4)
or M8 amyloid fibers. Dots represent 2-mL drops
of 20 mM proteins grown without agitation at
pH 7.4 and 37C.
1240 Berthelot et al.adding a final concentration of 1 phosphate-buffered saline (PBS; MP
Biomedicals Europe, Illkirch, France). Fiber polymerization was usually
considered to be complete after three days at 37C without agitation.
Anti-His-tag antibodies (Amersham, Piscataway, NJ) and Ponceau Red
(Sigma-Aldrich) were used to detect aggregates on nitrocellulose
membranes (Optitran BA-S83; Schleicher & Schuell, Dassel, Germany).
Antibody binding was visualized using a Dura chemoluminescence kit
(Pierce, Thermo Fisher Scientific, San Jose, CA) with the Quantity One
software/VersaDoc Imaging system (Bio-Rad, Hercules, CA).Congo Red binding properties
All kinetics experiments were performed at 37C and with 20 mM
proteins in PBS. A 20-mM solution of Congo Red (CR; cat. No. C.I.
22120; Sigma-Aldrich) in PBS was prepared (extinction coefficient at
498 nm ~3.7 104 M1 cm1) and filtered through a 0.22-mm polyether
sulfone filter. Absorbance spectra with Congo Red (5 mL CR for 100 mL
samples) were collected with a POLARstar Omega microplate reader
(BMG Labtech, Champigny-sur-Marne, France). Red shifts were observed
and respective displacement peaks were recorded. For microscopic analysis
of CR staining, aggregates were centrifuged and spread on microscope
slides. CR binding and birefringence were observed using an ECLIPSE
E600FN microscope (Nikon, Tokyo, Japan) with a PlanFluor 40 objective
and a DXM1200 digital camera (Nikon) equipped with optimally aligned
cross-polarizers. Three independent kinetics studies were performed with
different freshly desalted samples.Transmission electronic microscopy
A 10-mL aliquot of aggregates was adsorbed 10 min onto Formvar-coated,
carbon-stabilized copper grids (200 mesh), washed four times with water,
and air-dried. Grids were then negatively stained with 15–20 drops of
freshly prepared 2% uranyl acetate in double-distilled water and filtered
with a 0.22-mm membrane (Millipore, Bedford, MA), dried with filter
paper, and examined with a TECNAI Biotwin transmission electron micro-
scope (Philips, Amsterdam, The Netherlands) at an accelerating voltage of
120 kV. Transmission electron microscopy (TEM) was performed at the
Sercomi platform of the Bordeaux Imaging Center, and image processing
and analysis were done with ImageJ Ver. 10.2 (National Institutes of Health,
Bethesda, MD).Dynamic light scattering
For dynamic light scattering (DLS) data, mean particle size and intensity
size distribution were measured with a Malvern Instrument ALV/CGS-3Biophysical Journal 99(4) 1239–1246multiangle compact goniometer system (Malvern Instrument, Orsay,
France) containing a HeNe laser source (l ¼ 632.8 nm and 22 mW output
power) under a scattering angle of 90. The temperature of the sample
holder was controlled via a recirculating water bath. The freshly prepared
sample (2 mL; 10 mM at pH 7.4) was filtered through a 0.22-mm filter,
gently mixed, and placed in a borosilicate 10 mm-diameter cylindrical
cuvette. The estimated hydrodynamic radii were calculated using an
ALV-Correlator 3.0 software (ALV, Langen, Germany); the experiments
were carried out using an autopilot function accumulating 30 measurements
per sample. DLS measurements were performed three times on three
different desalted samples.Attenuated total reflectance-Fourier transform
infrared spectroscopy
To resolve the structure at pH 2.0, soluble proteins were desalted in 10 mM
DCl/D2O, under nitrogen environment to avoid H2O exchange (Sigma-
Aldrich; and Euriso-Top, Saint Aubain, France), and Fourier-transform
infrared (FTIR) spectra were recorded in solution using a CaF2 cell
(50 mm). Proteins in DCl were at 200 mM (WT) and 165 mM (M8). FTIR
and attenuated total reflectance (ATR)-FTIR spectra were recorded on a
Nexus 870 FTIR spectrometer equipped with a deuterated triglycine sulfate
detector (Nicolet, Thermo Fisher Scientific), with a spectral resolution of
4 cm1 and a one-level zero filling. One-hundred interferograms, represent-
ing an acquisition time of 3.5 min, were co-added. The methods used
for analysis and deconvolutions of ATR-FTIR spectra are presented in
Table S1 in the Supporting Material. For kinetics studies, the samples
were desalted in 10 mM HCl, and then were buffered with 1 PBS at pH
7.4 to a final concentration of 50 mM. Time 0 (T0) of kinetics corresponded
to the addition of PBS. Fibers were grown at 37C without agitation. The
first measurement was done after 5 min drying of a 5-mL drop onto the
germanium ATR crystal (Specac, Orpington, UK). All the aliquots gener-
ated during the kinetics were analyzed after 5 min drying. For CR binding
experiments on soluble proteins, CR was added at T0 and the spectra were
recorded on ATR-FTIR after three days. The fiber samples (final) obtained
previously were also analyzed in presence of CR in the same way.RESULTS
Soluble forms of WT and M8 are structurally
distinct
The M8 mutant primary sequence presents 10 mutations in
comparison to WT (86% identical; Fig. 1 A), but proteins
Toxic Amyloids Form Antiparallel b-Sheet 1241remain quite similar in terms of MW, pI, net charge, and
hydrophobicity (see Table S1 and Fig. S1). Both purified
proteins bear a His-tag sequence that may be recognized
by specific antibodies. This tag in the WTamyloid protrudes
outside of the axis fiber (18). However, this antibody did not
recognize the soluble form of WT proteins, but instead was
recognizing only WT fibers that appear during the incuba-
tion (Fig. 1 B). At the opposite, it was only binding to
soluble M8 but not to the amyloid M8 fibers formed during
the aggregation process (Fig. 1 C). Our results are consistent
with the progressive burial of the His-tag in the M8 fiber
structure during its formation. One possible explanation
for the nondetection of the native WT is that the C-terminal
end of the protein is contained within a random coil or loop
conformation, impeding access of antibodies to the His-tag.
We observed another unusual pattern of behavior when weanalyzed the kinetics of Congo Red (CR) staining (Fig. 2 A).
As expected, CR binding to WTand M8 increased over time
with the formation of aggregates. However, at T0, soluble
M8 binds efficiently to CR with a strong red shift and
high turbidity (Fig. 2 A). It was therefore astounding to
discover that soluble M8 was indeed immediately precipi-
tated in presence of CR. These CR/M8 aggregates analyzed
by ATR-FTIR have the same antiparallel b-sheet organiza-
tion as the M8 fibers stained a posteriori by CR (Fig. 2 B).
This observation led us to conclude that CR seemed to cata-
lyze M8 polymerization into amyloids. We observed the
same kind of precipitation of M8 with Thioflavine T and
8-Anilino-1-naphthalenesulfonic acid (data not shown). In
contrast, CR inhibited the fibrilization of WT by keeping
the soluble proteins in a random coil conformation as
observed by ATR-FTIR (Fig. 2B). This role of CR isFIGURE 2 Aggregation of WT and M8 in pres-
ence of Congo Red (CR). (A) Kinetics of amyloid
formation followed by CR binding. CR has a clas-
sical absorbance peak at 485 nm. CR was added
after polymerization and absorbance spectra re-
corded. For WT, the binding increases over time
during the formation of amyloid fibers and a red
shift is seen at 508 nm. For M8, an immediate
precipitation occurs in the presence of Congo
Red, concomitant with a high turbidity and a red
shift at 515 nm. (B) ATR-FTIR analysis of species
formed in presence of CR. After three days, soluble
WT species in the presence of CR remain in
random coils (dotted spectra), whereas fiber aggre-
gates exhibit specific parallel b-sheets. In such
conditions, CR is an inhibitor of aggregation
(sample 0 min is identical to CR). In contrast,
M8 aggregated instantly in presence of CR (sample
0 min is identical to sample final). ATR-FTIR
shows that the M8/CR complex is also an amyloid
with the same antiparallel b-sheet content as that
seen in the mature amyloid fibers. (C) All aggre-
gates formed were stained by CR and showed
birefringence under a polarized light microscope.
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1242 Berthelot et al.consistent with previous findings that characterized this dye
as an inhibitor of amyloid polymerization (20). However,
in 2010, two distinct publications (21,22) reported that Ab
(1–40) interacted with CR as M8, promoting b-sheet forma-
tion and peptide aggregation. Thus, this is the third report of
CR-amyloid binding behavior of toxic amyloids differing
from all other previous reports. Our results clearly suggest
the existence of different amyloids with different behaviors,
which may explain the differences in toxicity between the
two proteins in yeast. D
100 nm





M8 60 min M8 100 min
M8 200 min
100 nm
FIGURE 3 M8 presents several different intermediates during polymeri-
zation, which can be detected by transmission electronic microscopy
(TEM). (A) Structure of HET-s(218-289) fibers obtained by solid-NMR in
a previous study (18). (B) We did not observe any intermediates formed
by the WT protein during the time period indicated, but detected rapidly
the appearance of protofibrils of various sizes, fibers, bundles of fibers, or
protein plaques of amorphous aggregates. The picture presents a large
bundle at 30 min. (C) Analysis of M8 polymerization over time showed
the appearance of several different intermediates characterized by round
oligomers, followed by short fibers of ~100  10 nm, which then seemed
to fuse laterally to form larger aggregates that were able to precipitate.
(D) Size of round oligomers was analyzed, and was ~10 nm in diameter,
consistent with the width of a basic M8 fiber.M8 shows visible intermediates
We then investigated fibrillogenesis of our proteins by TEM.
Solid-state NMR has previously been used for the elegant
analysis of WT fiber three-dimensional structure. The
refined model shows that the WT fiber forms a left-handed
b-solenoid (Fig. 3 A), with monomers composed of four
b-strands (18); however, nothing is known about potential
intermediates. For the WT protein, we were not able to
detect any species other than protofibrils, larger fibers, and
bundles of fibers. Bundles of WT fibers were present as
soon as 30 min (Fig. 3 B). This may reflect either a very
fast kinetics of amyloid formation that would lead to tran-
sient intermediates not detectable by such approach or by
a real absence of any putative intermediates. This reproduc-
ible result was quite different with M8. In contrast, the
assembly of M8 aggregates over time was markedly dif-
ferent (Fig. 3 C). First, we detected the appearance of spher-
ical oligomers, ~10 nm in diameter (Fig. 3 D), followed by
the appearance of nanofibers of ~10  100 nm, which we
had previously observed (19). These fibers seemed to further
assemble into larger aggregates by merging. This was
confirmed by DLS (see Fig. 4). Unlike TEM, DLS allows
the evaluation of the particle size distribution in situ, for
the whole sample in solution. We did not detect any interme-
diate species for WT, at 37C in the 1–1000-nm range of
detection (data not shown). We slowed down the experiment
by decreasing the temperature at 15C, but only observed
initial small species followed by huge species at a later stage
(Fig. 4 A). M8 displayed a different pattern of behavior in
solution: species in the nanometer order were detected
initially, growing into aggregates of 100–200 nm, which
then became larger, before precipitating out of solution
(Fig. 4 B). The differences in findings between TEM and
DLS can be explained by the different states of the samples
(dried/stained and hydrated/dynamic). It would be of
interest to determine the specificity of these intermediates,
as this could also be a factor explaining M8 toxicity.M8 is inherently structured in solution at pH 7.4
Before starting analyzing structures over time, we first
needed to establish what the initial structuration of our
proteins was after purification. To perform FTIR in solution,Biophysical Journal 99(4) 1239–1246we could only do so by exchanging H2O/HCl by D2O/DCl
to avoid a strong interference with the vibration mode of
H2O (dO-H) at 1640 cm
1, in the amide I band range. At
pH 2.0, just after desalting in 10 mM DCl/D2O, the amide
I0 bands were observed at 1646 cm1 and 1648 cm1 for
WT and M8, respectively (Fig. 5 A). These wavenumbers
indicate that both WT and M8 at pD 2.0 were unstructured
in a mainly random coil conformation. The exchange
H2O/D2O induces a small shift of the wavenumber of
the amide I, as expected (23,24). The area of amide II
(1550 cm1) permits quantification of percentage of unex-
changed amide group, and the area of amide II0, measures
the percentage of exchanged amides. Fig. 5 A reveals that
for both WT and M8, only the amide II0 are observed,
FIGURE 4 DLS size distribution graphs of WT and M8 during aggrega-
tion. (A) WT proteins did not form any intermediate species visible in the
range of the DLS detection (from 1 to 1000 nm; gray shaded); we observed
only smaller and then bigger species. (B) M8 formed a number of interme-
diates in the range of detection. Fibrilization experiments were carried out
at a concentration of 10 mM, at 15C and without agitation.
Toxic Amyloids Form Antiparallel b-Sheet 1243leading us to conclude to a complete exchange of the NH to
ND in presence of D2O. The random coil conformations of
WT and M8 favor this large exchange. Thus, at pD 2.0, the
nontoxic WT and the toxic M8 are unstructured, according
to the profile of the amide I0 and the complete exchange
with D2O.
Secondly, we used ATR-FTIR to investigate the changes
in structure over time during amyloid polymerization
after air-drying the sample. The amide I band recorded was
deconvoluted into four main structures: random coils
(1655 cm1), b-turns (1669 cm1), and parallel (1630 cm1)
and antiparallel b-sheets (1619 and 1692 cm1), character-
istic of amyloids (Table S1). As expected, WT underwent
a molecular transition from a random coil organization
(main peak at 1655 cm1; Fig. 5 B), with a predominance
of b-turns, to amainly parallel b-sheet amyloid conformation
as described by NMR (18). Under our experimental condi-
tions, this transition occurred after a lag phase of ~40 min
(Fig. 5 C), possibly corresponding to a slow nucleation
process. Surprisingly, M8 behaved very differently. M8
assembled immediately into antiparallel b-sheets when pH
was raised to 7.4, as reflected by the characteristic 1619-
and 1692-cm1 peaks (Fig. 5 B). These contributions were
observed on the first spectra after 5 min drying. We did not
observe any lag phase, as if the monomer was instantly
assembled into mainly antiparallel b-sheets (Fig. 5 C).
During M8 fibrilization, we only observed a small change
of structure, an increase of the percentage of amide group
organized in antiparallel b-sheets (>10%) at the expense of
the random coils and b-turns. M8 was therefore forming
a more stable antiparallel b-sheet conformation.DISCUSSION
In terms of kinetics, it is truly impossible to compare the
different approaches we chose to use, because of therestraints due to the technical approaches (concentrations,
temperatures, etc.). Other conditions such as pH, ionic
strength, oxidation, reacting volumes, test tube shape and
composition, and shaking/mixing can also be key factors
during polymerization (8,25). Moreover, surfaces and inter-
faces may influence greatly aggregation characteristics
(26,27). Each technique was a powerful analysis method,
but with resolution limits and inherent constraints. For
example, TEM may provide partial or biased information,
as samples may differently interact with the grid. In this
case, the object under scrutiny is washed, dried, and stained,
which could be very different from its bulk solution state.
DLS is performed in solution, but only convenient for small
assembly in the 1–1000-nm range. Big aggregates usually
keep out of sight the smaller ones in the light scattering.
Amyloid-dye (8-Anilino-1-naphthalenesulfonic acid, Thio-
flavine T, and Congo Red) staining is not very specific, as
not all amyloids react the same way in presence of these
dyes, and other polymers such as actin may also bind to
CR (28). Because of high concentration detection limits
and superposition of H20 vibration in the amide I band, it
is almost impossible to work in solution with FTIR. The
use of ATR is more appropriate to our samples but cannot
exclude that amyloids get structured by contact or drying
on the ATR crystal.
In any case, our work aimed to compare two amyloids:
one toxic and the other not. And we clearly demonstrated
here that WT and M8 amyloids display no similarities in
aggregation kinetics or structure, aggregate morphology,
or size. In our various experimental conditions, the two
amyloids polymerized through apparently different path-
ways, involving different intermediates. We thus proposed
two distinct models of amyloidogenesis (Fig. 6). The first
pathway is that of the wild-type, which is similar to a nucle-
ation-dependent fibrilization model previously proposed
(29,30). This involves a nucleation step, which is usually
quite slow (k1), and is followed by a quicker elongation of
the fibril from the nucleus (k2). This model can also refer
to other parameters in amyloid aggregation as secondary
nucleation phenomena, seeding, or fragmentability (31,32).
Curiously, during this lag-time, no changes in the level of
aggregation could be detected whatever the technique
used (DLS, TEM). Under our experimental conditions,
and with the techniques we used, we could not detect the
nucleus. This could be due to the smallness of the nucleus
that would not be distinguished from the monomeric
species. Then the fibril was assembled from the free native
monomers and was elongated into a kind of template-assis-
ted b-sheet structure. Protofibrils (5-nm large) formed from
these WT monomers formed the basis of larger quaternary
structures organized into a highly hydrated network, giving
the aggregates the appearance of a gel (Fig. 2 C). These
HET-s(218–289) fibril structures have been fully described
by solid-state NMR, TEM, or the tilted-beam-TEM
(18,33,34). The second pathway of M8 is clearly differentBiophysical Journal 99(4) 1239–1246
FIGURE 5 Structures of WT and M8 intermedi-
ates followed by FTIR and ATR-FTIR. (A) FTIR
spectra of WT and M8 proteins at pH 2.0 in DCl.
Maximum absorbance peaks were observed at
1646 nm for WT and 1648 nm for M8, character-
istic of a random coil conformation in D2O.
Proteins were desalted in 10 mM DCl in D2O
and were used at 200 mM (WT) and 165 mM
(M8), respectively. (B) Aggregation kinetics
shown by infrared spectra of air-dried (5 min)
WT and M8 displaying different structural transi-
tions. WT undergoes a clear transition from
random coil to a mainly parallel b-sheet structure,
whereas M8 seems to instantly form antiparallel
b-sheets, which are then modified over time. (C)
Structural evolution of amyloid species over time
for WT and M8 expressed as percentages of
random coils, b-turns, and parallel and antiparallel
b-sheets. Kinetics were performed at a concentra-
tion of 50 mM, pH 7.4 and 37C without agitation.
Smooth curves are presented.
1244 Berthelot et al.and more straightforward; the nucleus is formed instantly
(k3), then oligomers form and fibrils grow, probably through
the fusion of 10-nm oligomers in diameter. In our particular
case, the basic fiber growth is limited to ~10  100 nm.
These short fibers did not display any tendency to twist or
interwind. Indeed, M8 fibers seemed to merge laterally to
form larger aggregates that appeared as, and precipitated
as, a finely granulated powder (Fig. 2 C).Does size matter?
Amyloid polymerization is a complex process, involving
several kinds of intermediates of various sizes and shapes.
However, the role of intermediates in determining toxicity,
particularly in neurodegenerative disorders, is highlyBiophysical Journal 99(4) 1239–1246contentious, probably due to their diversity. Indeed, the
mechanism through which neuronal death is triggered
remains unexplained. Several hypotheses have been pro-
posed, all of which involve interactions with biological
membranes. Most publications suggest that soluble oligo-
mers and prefibrillar intermediates are the toxic species
(3,5,35), but sometimes fibers or mature aggregates are
also suspected. Amyloid intermediates may bind (36) or
insert into membranes (37), and cause membrane permeabi-
lization and leakage (15) or membrane disruption and
damage (14). Some seem to be involved in the formation
of channels or annular pores, which can modify cellular
homeostasis (9,10,38). A recent study has also demonstrated
that large fibrillar amyloids are able to cross a membrane
barrier and may be internalized in the cytoplasm of
FIGURE 6 Two different models of amyloid polymerization. (A)
Proposed proceeding of amyloidogenesis followed by HET-s(218-289). The
soluble random coil monomer is subjected to a slow nucleation process
(k1) and the nucleus formed is barely detectable. A rapid elongation then
takes place (k2) by addition of unfolded monomers in a sort of template-
assisted b-sheet structuration. The protofibril grew with the addition of
soluble monomers, and then formed more complex and twisted fibers and
bundles. (B) M8 amyloid followed a different pathway of aggregation.
The soluble random coil form of M8 was only observed at pH 2.0. At
pH 7.4, the process of polymerization started instantly (k3) by forming anti-
parallel b-sheet species. These species assembled into 10-nm-diameter
oligomers and then into short fibers (~10  100 nm).
Toxic Amyloids Form Antiparallel b-Sheet 1245mammalian cells (39). Additionally, some lipids may cata-
lyze the fibrillogenesis pathway (40) and specific membrane
components may trigger changes in the conformation of
amyloids (41). Interestingly, lipids may resolubilize mature
nontoxic amyloid fibers into toxic oligomers (16).
Our results show that highly similar sequences (86%
identical) can lead to completely different ordered aggre-
gates that display very different aggregation properties
and cytotoxicity. Our evidences lead us to think that the
kinetics of M8 aggregation is at the origin of its toxicity.
The aggregation dynamics demonstrate the capacity of M8
to assemble into intermediates species that may be reminis-
cent of oligomeric toxic intermediates. Interestingly, the
antiparallel signature of these toxic species is consistent
with the antiparallel organization of Ab(1–42) toxic oligo-
mers recently published (42). In addition, it has been shown
that fibril length is also correlated with the ability to disrupt
membranes and to reduce cell viability (8). In parallel, we
have carried out preliminary studies showing that M8 mayclearly interfere with vesicular trafficking in vivo (43) and
that it interacts in vitro specifically at the interface with
various lipid monolayers (H. P. Ta, K. Berthelot, B. Desbat,
J. Ge´an, L. Servant, C. Cullin, and S. Lecomte, unpublished
data), which may explain its toxicity in yeast. It may now be
of interest to investigate the fusogenic activity of our toxic
amyloids. Such activity has already been suggested to
play a role in PrP and amyloid-b toxicity (44,45). Our model
based only on the gain of toxicity function is of general
interest. Indeed, of the biochemical characteristics found
for this particular toxic amyloid, we found specific features
related to other amyloids involved in pathological events.
Here, we have shown that in addition to a remarkable pattern
of nanofibril formation, M8 displays a rapid kinetics with no
lag-phase and forms highly structured oligomers. Our model
opens up new perspectives to study the origins of the toxic
properties of amyloids.SUPPORTING MATERIAL
Two tables and one figure are available at http://www.biophysj.org/
biophysj/supplemental/S0006-3495(10)00726-5.
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